Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
|
|
14.
|
|
|
15.
|
|
|
16.
|
|
|
17.
|
The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial. [electronic resource] by
- Boggs, Douglas L
- Surti, Toral
- Gupta, Aarti
- Gupta, Swapnil
- Niciu, Mark
- Pittman, Brian
- Schnakenberg Martin, Ashley M
- Thurnauer, Halle
- Davies, Andrew
- D'Souza, Deepak C
- Ranganathan, Mohini
Producer: 20190313
In:
Psychopharmacology vol. 235
Availability: No items available.
|
|
18.
|
Efficacy and safety of a fatty acid amide hydrolase inhibitor (PF-04457845) in the treatment of cannabis withdrawal and dependence in men: a double-blind, placebo-controlled, parallel group, phase 2a single-site randomised controlled trial. [electronic resource] by
- D'Souza, Deepak Cyril
- Cortes-Briones, Jose
- Creatura, Gina
- Bluez, Grai
- Thurnauer, Halle
- Deaso, Emma
- Bielen, Kim
- Surti, Toral
- Radhakrishnan, Rajiv
- Gupta, Aarti
- Gupta, Swapnil
- Cahill, John
- Sherif, Mohamed A
- Makriyannis, Alexandros
- Morgan, Peter T
- Ranganathan, Mohini
- Skosnik, Patrick D
Producer: 20190726
In:
The lancet. Psychiatry vol. 6
Availability: No items available.
|